ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet


















Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Mirror Bacteria: An AMR threat of unprecedented magnitude
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
Draft EMA antibacterial guidance: Analysis
NIAID workshop: What is a robust PK-PD package?
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
Modeling the value of an effective antibiotic — Megiddo et al.
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
Chemical vs. drugs (Part 2): How do you discriminate? / More on halicin
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet

The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet